Superior Planning, LLC’s Regencell Bioscience RGC Stock Holding History

Superior Planning, LLC’s Portfolio RGC Stock Details RGC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.56K	Buy	+251	New	+$1.45K	﹤0.01%	1636

Other funds holding RGC

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Jane Street New York $1.19T AUM 51.51% 1-Year Est. Return

Savant Capital Rockford, Illinois $35B AUM 15.18% 1-Year Est. Return

CIBC Asset Management Toronto, Ontario, Canada $47B AUM 34.17% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $83.6B AUM 19.78% 1-Year Est. Return

Larson Financial Group St Louis, Missouri $4.11B AUM 23.62% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return

EverSource Wealth Advisors Birmingham, Alabama $3.11B AUM 21.48% 1-Year Est. Return

Ameritas Advisory Services Lincoln, Nebraska $5.22B AUM 19.55% 1-Year Est. Return

Superior Planning, LLC's RGC Position: Q3 2026 in Review

Superior Planning, LLC opened a new position in Regencell Bioscience (RGC) in Q3 2026: 251 shares worth $1.56K. The stake represents ﹤0.01% of the portfolio and ranks #1636 among its holdings.

18 funds tracked by Wall St. Rank hold RGC as of Q3 2026.

Superior Planning, LLC held 251 shares of Regencell Bioscience worth $1.56K as of Q3 2026.
Regencell Bioscience was a new Superior Planning, LLC position in Q3 2026.
Regencell Bioscience made up ﹤0.01% of Superior Planning, LLC's portfolio in Q3 2026, its #1636 holding.
18 funds tracked by Wall St. Rank held Regencell Bioscience as of Q3 2026.

Based on Superior Planning, LLC's 13F filing for Q3 2026, filed 12 Nov 2026.